Status of research on MMPs in India

Bibliography

• Ambili M, Sudhakaran PR. 60K Gelatinase in involuting rat mammary gland is produced as a 90K proenzyme. Biochem Mol Biol Int 1998;45:389-99
   PubMedGoogle Scholar
• Ambili M, Jayasree K, Sudhakaran PR. 60K gelatinase involved in mammary gland involution is regulated by beta-oestradiol. Biochim Biophys Acta 1998;1403:219-31
   PubMed Web of Science ®Google Scholar
• Sudhakaran PR, Ambili M, Philip S. Matrix metalloproteinase in mammary gland remodeling-modulation by glycosaminoglycans. Biosci Rep 1999;19:485-90
   PubMed Web of Science ®Google Scholar
• Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 1998;2:466-71
   PubMed Web of Science ®Google Scholar
• Dong JC, Dong H, Campana A, Bischof P. Matrix metalloproteinases and their specific tissue inhibitors in menstruation. Reproduction 2002;123:621-31
   PubMed Web of Science ®Google Scholar
• Roy R, Zhang B, Moses MA. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 2006;312:608-22
   PubMed Web of Science ®Google Scholar
• Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem 1995;376:345-55
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circ Res 2003;92:827-39
   PubMed Web of Science ®Google Scholar
• Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008;29:290-308
   PubMed Web of Science ®Google Scholar
• Ganguly K, Swarnakar S. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res 2009;47:43-55
   PubMed Web of Science ®Google Scholar
• Gautam R, Jachak SM. Recent developments in anti inflammatory natural products. Med Res Rev 2009;29:767-820
   PubMed Web of Science ®Google Scholar
• Mandal M, Mandal A, Das S, Clinical implications of matrix metalloproteinases. Mol Cell Biochem 2003;252:305-29
   PubMed Web of Science ®Google Scholar
• Bigg HF, Rowan AD. The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis. Curr Opin Pharmacol 2001;1:314-20
   PubMedGoogle Scholar
• Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 2006;26:299-307
   PubMed Web of Science ®Google Scholar
• Dev R, Srivastava PK, Iyer JP, Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain. Expert Opin Investig Drugs 2010;19:1-14
   PubMed Web of Science ®Google Scholar
• Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1-31
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75:346-59
   PubMed Web of Science ®Google Scholar
• Tan J, Hua Q, Xing X, Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Hypertens Res 2007;30:959-63
   PubMed Web of Science ®Google Scholar
• Srivastava PK, Dastidar SG, Ray A. Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy. Expert Opin Investig Drugs 2007;16:1069-78
   PubMed Web of Science ®Google Scholar
• Castelhano AL, Billedeau R, Dewdney N, Novel indolactam-based inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1995;5:1415-20
   Web of Science ®Google Scholar
• Acharya MR, Venitz J, Figg WD, Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist Update 2004;7:195-208
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Poole C, Primrose J, Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies. Clin Cancer Res 1998;4:1101-9
   PubMed Web of Science ®Google Scholar
• Rhomberg W. Marimastat (British Biotech plc.). Curr Opin Oncol Endocr Metab Invest Drugs 1999;1:7-24
   Google Scholar
• Jacob SS, Shastry P, Sudhakaran PR. Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation. Atherosclerosis 2001;159:333-41
   PubMed Web of Science ®Google Scholar
• Philip S, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappaB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 2001;276:44926-35
   PubMed Web of Science ®Google Scholar
• Rangaswami H, Bulbule A, Kundu GC. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 2004;279:38921-35
   PubMed Web of Science ®Google Scholar
• Philip S, Kundu GC. Osteopontin induces nuclear factor kappaB-mediated promatrix metalloproteinase-2 activation through IkappaBalpha/IKK signaling pathways, and curcumin (Diferulolylmethane) down-regulates these pathways. J Biol Chem 2003;278:14487-97
   PubMed Web of Science ®Google Scholar
• Kiran MS, Sameerkumar VB, Viji RI, Sudhakaran PR. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Int 2006;30:704-13
   PubMed Web of Science ®Google Scholar
• Patel BP, Shah PM, Rawal UM, Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 2005;90:81-8
   PubMed Web of Science ®Google Scholar
• Patel BP, Shah SV, Shukla SN, Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 2007;29:564-72
   PubMed Web of Science ®Google Scholar
• Nagini S, Letchoumy PV, Thangavelu A, Ramachandran CR. Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol 2009;45:e31-7
   PubMed Web of Science ®Google Scholar
• Bindhu OS, Ramadas K, Sebastian P, Pillai MR. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 2006;28:916-25
   PubMed Web of Science ®Google Scholar
• Loercher A, Lee TL, Ricker JL, Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004;64:6511-23
   PubMed Web of Science ®Google Scholar
• Soni S, Mathur M, Shukla NK, Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003;107:309-16
   PubMed Web of Science ®Google Scholar
• Samantaray S, Sharma R, Chattopadhyaya TK, Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004;130:37-44
   PubMed Web of Science ®Google Scholar
• Mathew R, Khanna R, Kumar R, Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 2002;26:222-8
   PubMedGoogle Scholar
• Pathak S, Bukhsh ARK. Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethyl aminoazobenzene and Phenobarbital. Exp Mol Pathol 2007;83:104-11
   PubMed Web of Science ®Google Scholar
• Bhattacharjee N, Banerjee P, Bukhsh ARK. Homeopathic drugs natrum sulphuricum and carcinosin prevent azo dye-induced hepatocarcinogenesis in mice. Indian J Biochem Biophys 2009;46:307-18
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan V, Devaraj SN. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Interact 2009;180:353-9
   PubMed Web of Science ®Google Scholar
• Janani P, Sivakumari K, Geetha A, Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma. Cell Biochem Funct 2010;28:164-9
   PubMed Web of Science ®Google Scholar
• Jacob S, Sudhakaran PR. Changes in the activity of matrix metalloproteinases in regenerating rat liver after CCl4–induced injury. Indian J Biochem Biophys 2003;40:324-9
   PubMed Web of Science ®Google Scholar
• Saja K, Sudhakaran PR. cAMP-mediated upregulation of gelatinases in primary cultures of isolated rat hepatocytes. Indian J Biochem Biophys 2004;41:294-8
   PubMed Web of Science ®Google Scholar
• Pranitha P, Sudhakaran PR. Fibronectin dependant upregulation of matrix metalloproteinases in hepatic stellate cells. Indian J Biochem Biophys 2003;40:409-15
   PubMed Web of Science ®Google Scholar
• Devipriya N, Sudheer AR, Srinivasan M, Menon VP. Effect of elagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity. Toxicol Mech Method 2007;17:349-56
   PubMed Web of Science ®Google Scholar
• Penumathsa SV, Kode A, Rajagopalan R, Menon VP. Changes in activities of MMP in alcohol and thermally oxidized sunflower oil-induced liver damage: NAC antioxidant therapy. Toxicol Mech Method 2006;16:267-74
   PubMed Web of Science ®Google Scholar
• Ramakrishnan G, Jagan S, Kamara S, Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Invest New Drugs 2009;27:23-40
   Web of Science ®Google Scholar
• Chandru H, Sharada AC, Manjunath S. Expression of matrix metalloproteinase (mmp-2) and extracellular matrix metalloproteinases inducer (EMMPRIN) in benign and advanced breast cancer tissue samples. Biochem Moscow Suppl B Biomed Chem 2007;1:348-52
   Google Scholar
• Shah FD, Shukla SN, Shah PM, Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer. Indian J Cancer 2009;46:194-202
   PubMedGoogle Scholar
• Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 2008;82:467-76
   PubMedGoogle Scholar
• Dutta A, Sen T, Chatterjee A. Culture of K562 human myeloid leukemia cells in presence of fibronectin expresses and secretes MMP-9 in serum free culture medium. Int J Clin Exp Pathol 2010;3:288-302
   PubMed Web of Science ®Google Scholar
• Dutta A, Sen T, Banerji A, Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7). J Oncol 2009;2009:627840
   PubMedGoogle Scholar
• Adhikary A, Mohanty S, Lahiry L, Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk. FEBS Lett 2010;584:7-14
   PubMed Web of Science ®Google Scholar
• Mathivadhani P, Shanthi P, Sachdanandam P. Effect of Semecarpus anacardium nut extract on ECM and proteases in mammary carcinoma rats. Vasc Pharmacol 2007;46:419-26
   PubMed Web of Science ®Google Scholar
• Premalatha B. Semecarpus anacardium Linn. nuts – a boon in alternative medicine. Indian J Exp Biol 2000;38:1177-82
   PubMedGoogle Scholar
• Nair SA, Karunagaran D, Nair MB, Sudhakaran PR. Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. J Cancer Res Clin Oncol 2003;129:123-31
   PubMed Web of Science ®Google Scholar
• Mitra A, Chakrabarti J, Das ABS, Chatterjee A. Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol 2006;132:505-13
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Mitra A, Frei E, Chatterjee A. Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matix metalloproteinase (MMP-2) activity. J Cancer Res Clin Oncol 2001;127:653-8
   PubMed Web of Science ®Google Scholar
• Maity G, Fahreen S, Banerji A, Fibronectin–integrin mediated signaling in human cervical cancer cells (SiHa). Mol Cell Biochem 2010;336:65-74
   PubMed Web of Science ®Google Scholar
• Jones LE, Humphreys MJ, Campbell F, Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004;10:2832-45
   PubMed Web of Science ®Google Scholar
• Jormsjo S, Whatling C, Dirk H, Allelespecific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2001;21:1834-9
   PubMed Web of Science ®Google Scholar
• Singh HO, Jain M, Mittal B. MMP-7 (−181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol 2008;110:71-5
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Singh M, Bharti AC, Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci 2010;17:10
   PubMed Web of Science ®Google Scholar
• Vijayababu MR, Arunkumar A, Kanagaraj P, Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 2006;287:109-16
   PubMed Web of Science ®Google Scholar
• Ferriola PC, Cody V, Middleton E Jr. Protein-kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationship. Biochem Pharmacol 1989;38:1617-24
   PubMed Web of Science ®Google Scholar
• Casagrande F, Darbon JM. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclindependent kinases CDK2 and CDK1. Biochem Pharmacol 2001;61:1205-15
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Tran E, Nguyen TH, The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004;25:647-59
   PubMed Web of Science ®Google Scholar
• Vijayababu MR, Kanagaraj P, Arunkumar A, Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 2005;131:765-71
   PubMed Web of Science ®Google Scholar
• Guruvayoorappan C, Kuttan G. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue. Integr Cancer Ther 2008;7:42-50
   PubMed Web of Science ®Google Scholar
• Guruvayoorappan C, Kuttan G. Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and cytokines in lung tissues of C57BL/6 mice. Immunopharm Immunotoxicol 2008;30:711-27
   PubMed Web of Science ®Google Scholar
• Manu KA, Kuttan G. Anti-metastatic potential of punarnavine, an alkaloid from Boerhaavia diffusa Linn. Immunobiology 2009;214:245-55
   PubMed Web of Science ®Google Scholar
• Vinodhkumar R, Song YS, Ravikumar V, Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Chem Biol Interact 2007;165:220-9
   PubMed Web of Science ®Google Scholar
• Sandya S, Achan MA, Sudhakaran PR. Multiple matrix metalloproteinases in type II collagen induced arthritis. Indian J Clin Biochem 2009;24:42-8
   PubMedGoogle Scholar
• Sandya S, Sudhakaran PR. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis. Exp Biol Med 2007;232:629-37
   Web of Science ®Google Scholar
• Kumar DA, Raju KVSN, Settu K, Effect of a derivatized tetrapeptide from lactoferrin on nitric oxide mediated matrix metalloproteinase-2 production by synovial fibroblasts in collagen-induced arthritis in rats. Peptides 2006;27:1434-42
   PubMed Web of Science ®Google Scholar
• Ganesan K, Tiwari M, Balachandran C, Estrogen and testosterone attenuate extracellular matrix loss in collagen-induced arthritis in rats. Calcif Tissue Int 2008;83:354-64
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Panda S, Misra R. Effect of etanercept on matrix metalloproteinases and angiogenic vascular endothelial growth factor: a time kinetic study. Ann Rheum Dis 2004;63:891-2
   PubMed Web of Science ®Google Scholar
• Sarma PK, Misra R, Aggarwal A. Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and proMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol 2008;27:289-94
   PubMed Web of Science ®Google Scholar
• Agarwal S, Misra R, Aggarwal A. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. Rheumatol Int 2009;29:907-11
   PubMed Web of Science ®Google Scholar
• Van der Heijden IM, Wilbrink B, Tchetverikov I. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000;43:593-8
   PubMed Web of Science ®Google Scholar
• Sieper J, Braun J, Doring E, Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis 1992;51:1208-14
   PubMed Web of Science ®Google Scholar
• Takasawa N, Munakata Y, Ishii KK, Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J Immunol 2004;173:4675-83
   PubMed Web of Science ®Google Scholar
• Zare F, Bokarewa M, Nenonen N, Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004;172:5656-63
   PubMed Web of Science ®Google Scholar
• Agarwal S, Misra R, Aggarwal A. Induction of metalloproteinases expression by TLR ligands in human fibroblast like synoviocytes from juvenile idiopathic arthritis patients. Indian J Med Res 2010;131:771-9
   PubMed Web of Science ®Google Scholar
• Swarnakar S, Ganguly K, Kundu P, Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 2005;280:9409-15
   PubMed Web of Science ®Google Scholar
• Srikanta BM, Sathisha UV, Dharmesh SM. Alterations of matrix metalloproteinases, gastric mucin and prostaglandin E2 levels by pectic polysaccharide of swallow root (Decalepis hamiltonii) during ulcer healing. Biochimie 2010;92:194-203
   PubMed Web of Science ®Google Scholar
• Ganguly K, Maity P, Reiter RJ, Swarnakar S. Effect of melatonin on secreted and induced matrix metalloproteinase-9 and -2 activity during prevention of indomethacin-induced gastric ulcer. J Pineal Res 2005;39:307-15
   PubMed Web of Science ®Google Scholar
• Ganguly K, Kundu P, Banerjee A, Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radical Biol Med 2006;41:911-25
   PubMed Web of Science ®Google Scholar
• Singh LP, Kundu P, Ganguly K, Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. Free Radical Biol Med 2007;43:289-99
   PubMed Web of Science ®Google Scholar
• Swarnakar S, Mishra A, Ganguly K, Sharma AV. Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007;43:56-64
   PubMed Web of Science ®Google Scholar
• Kundu P, Mukhopadhyay AK, Patra R, Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 2006;281:34651-62
   PubMed Web of Science ®Google Scholar
• Manikandan P, Murugan RS, Priyadarsini RV, Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 2010;86:936-41
   PubMed Web of Science ®Google Scholar
• Jamloki A, Karthikeyan C, Moorthy NSHN, Trivedi P. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase. Bioorg Med Chem Lett 2006;16:3847-54
   PubMed Web of Science ®Google Scholar
• Gupta SP, Bagaria P, Satuluri VSAK. A quantitative structure-activity relationship study on some Aryl Sulfonyl Amido and Ureido derivatives acting as matrix metalloproteinase and Clostridium histolyticum collagenase inhibitors. Lett Drug Des Discov 2007;4:496-501
   Web of Science ®Google Scholar
• Sarma JARP, Rambabu G, Srikanth K, Analogue based design of MMP-13 (collagenase-3) inhibitors. Bioorg Med Chem Lett 2002;12:2689-93
   PubMed Web of Science ®Google Scholar
• Gupta SP. Quantitative structure-activity relationship studies on zinc-containing metalloproteinase inhibitors. Chem Rev 2007;107:3042-87
   PubMed Web of Science ®Google Scholar
• Lohray BB, Lohray VB, Jain MR, Novel substituted hydroxamic acid derivatives having MMP and TNF inhibitory activities. IN2003MU00236; 2005
   Google Scholar
• Das UN. Method of stabilizing and potentiating the action of anti-angiogenic substances. IN2004CH01157; 2007
   Google Scholar
• Sattigeri VJ, Palle VP, Khera MK, Preparation of uronic acid derivatives as metalloproteinase inhibitors. WO2008023336; 2008
   Google Scholar
• Overall CM, Kleifeld O. Towards third generation matrix metalloproteinase inhibitor for cancer therapy. Br J Cancer 2006;94:941-6
   PubMed Web of Science ®Google Scholar
• Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. Available from: http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf [Last accessed 25 October 2010]
   Google Scholar
• Jarbrink MQ, Smith DA, Bancroft GJ. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001;69:5661-70
   PubMed Web of Science ®Google Scholar
• Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009;8:205-16
   PubMed Web of Science ®Google Scholar